Table: begin end state 1 33 cytoplasmic 34 54 transmembrane 55 60 non-cytoplasmic 61 85 transmembrane 86 95 cytoplasmic 96 117 transmembrane 118 123 non-cytoplasmic 124 144 transmembrane 145 164 cytoplasmic 165 184 transmembrane 185 195 non-cytoplasmic 196 215 transmembrane 216 247 cytoplasmic 248 268 transmembrane 269 283 non-cytoplasmic 284 302 transmembrane 303 313 cytoplasmic 314 334 transmembrane 335 340 non-cytoplasmic 341 362 transmembrane 363 373 cytoplasmic 374 396 transmembrane 397 407 non-cytoplasmic 408 426 transmembrane 427 435 cytoplasmic
Input: >BPHYT_RS27905 FitnessBrowser__BFirm:BPHYT_RS27905 MHETTPAELDAATRPLRRRSALRSIAGGSIGNLIEWYDFHVYTTFSIFFAASFFPRENRT IQLLSTAAIFAIGFLLRPVGSWLIGLYADRRGRRSALTLSVILMCAGSLAIGLCPTYPQI GMAAPLVLLLARLVQGFSLGGEYGASSVYLSEIARPGHRGFYSSFHYVTLILGQLLATLV QVVLQALIPRAELIDWGWRVPFITGAALALVAWWVRRNIDETPDFRALDEKDKRGVSLSA LREHWRPVLLVFGLTTGGTLAFFTYTVYMHNYLVNTVGLSAQTSAWLSLSTLTLFMVVQP FFGALSDRIGRRPLLLWFGIGGTFGTWPLLTALAHTHSATTAFLLLALALMIVSGYTSVC SVMKAQLFPARLRALGVGVPYAIATAVFGGTASYAGLWFKSIGHESGFYLYASACIGCTL IATLSLRSSDMKMES
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server